Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 5/20 | 1.00 |
| ▸ | LTA4H | P09960 | 5/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.98 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.98 |
| ▸ | CYP2C8 | P10632 | 4/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.98 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.98 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.98 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.98 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.98 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | MTOR | P42345 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4886648 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL29564343 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL4886657 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL30335074 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL29564502 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL29929375 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL4885150 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| Shogaol SCHEMBL971812 | 0.99 | LTA4H (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| Shogaol SCHEMBL10523393 | 0.99 | LTA4H (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| Shogaol SCHEMBL49054 | 0.99 | LTA4H (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| US-12588699-B2 | Aerosol-generating substrate | PHILIP MORRIS PRODUCTS S.A. (CH) | 2026-03-31 | — | — | US | disclosed |
| US-12342845-B2 | Aerosol-generating substrate comprising Zingiber species | PHILIP MORRIS PRODUCTS S.A. (CH) | 2025-07-01 | — | — | US | disclosed |
| EP-4048095-B1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ZINGIBER SPECIES | PHILIP MORRIS PRODUCTS SA (CH) | 2023-11-29 | — | — | EP | disclosed |
| US-20230346001-A1 | NOVEL AEROSOL-GENERATING SUBSTRATE | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-11-02 | — | — | US | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| CN-115666278-A | Novel aerosol-generating substrate | 菲利普莫里斯生产公司 | 2023-01-31 | — | — | CN | disclosed |
| EP-4110093-A1 | NOVEL AEROSOL-GENERATING SUBSTRATE | Philip Morris Products S.A. (CH) | 2023-01-04 | — | — | EP | disclosed |
| US-11540539-B2 | Reduced sodium food products | GENERAL MILLS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20220369690-A1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ZINGIBER SPECIES | PHILIP MORRIS PRODUCTS S.A. (CH) | 2022-11-24 | — | — | US | disclosed |
| US-20150283193-A9 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | LIFELINE NUTRACEUTICALS (US) | 2015-10-08 | — | — | US | disclosed |
| US-20140271944-A1 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | LIFELINE NUTRACEUTICALS (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140271944-A1 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | LIFELINE NUTRACEUTICALS (US) | 2014-09-18 | — | — | US | disclosed |
| US-7728043-B2 | Methods for treatment of beta-amyloid protein-induced ocular disease | KIM DARRICK S H L | 2010-06-01 | — | — | US | disclosed |
| US-7572829-B2 | Pharmaceutical compositions useful in prevention and treatment of Beta-amyloid protein-induced disease | KIM DARRICK S H L | 2009-08-11 | — | — | US | disclosed |
| US-20090011059-A1 | Ginger Extract For Inhibiting Human Drug Transporters | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-01-08 | — | — | US | disclosed |
| US-20080085932-A1 | Pharmaceutical Compositions Useful In Prevention and Treatment of Beta-Amyloid Protein-Induced Disease | KIM DARRICK S | 2008-04-10 | — | — | US | disclosed |
| US-20080038386-A1 | Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition | MOZA ASHOK K | 2008-02-14 | — | — | US | disclosed |
| WO-2007071721-A2 | GINGER EXTRACT FOR INHIBITING HUMAN DRUG TRANSPORTERS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-06-28 | — | — | WO | disclosed |
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | KIM DARRICK S H | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | APP, BACE1, GSAP | HTR1A 2494/4885LTA4H 1783/4885CYP3A4 3043/4885 |
| US-20090011059-A1 | Ginger Extract For Inhibiting Human Drug Transporters | ABCB1, SLCO1B1, ABCG2 | HTR1A 1373/4885LTA4H 2604/4885CYP3A4 151/4885 |
| US-20140271944-A1 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | GSTO1, GSTK1, GSTP1 | HTR1A 4032/4885LTA4H 504/4885CYP3A4 1302/4885 |
| US-20080085932-A1 | Pharmaceutical Compositions Useful In Prevention and Treatment of Beta-Amyloid Protein-Induced Disease | APP, BACE1, PSEN1 | HTR1A 2714/4885LTA4H 971/4885CYP3A4 733/4885 |
| US-20150283193-A9 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | GSTO1, GSTK1, GSTP1 | HTR1A 4032/4885LTA4H 504/4885CYP3A4 1302/4885 |
| US-12588699-B2 | Aerosol-generating substrate | CCT5, PRUNE1, DSTN | HTR1A 2279/4885LTA4H 3290/4885CYP3A4 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.